Home Tags Biomarkers

biomarkers Related Content

bipolar disorder patients, LEF1

Why doesn’t lithium work for 70% of bipolar disorder patients?

Salk Institute scientists believe they have solved this mystery for bipolar disorder patients - the answer involves a specific gene, and proposes changes to the future of treatment.
cancer detection, OPMD

Deciphering molecular intelligence for early oral cancer detection

Muy-Teck Teh, Senior Lecturer from Barts and the London School of Medicine & Dentistry, Queen Mary University of London discusses how a novel low-cost rapid digital diagnostic test could help save lives and reduce head and neck cancer burden worldwide.
dementia during the COVID-19 pandemic, frost and sullivan

China: How to deal with dementia during the COVID-19 pandemic

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, China charts how to deal with dementia during the COVID-19 pandemic, starting with a helpful global and regional overview.
biomarkers

Technology focus: Social impact analysis using voice biomarkers

Shinichi Tokuno from the University of Tokyo walks us through voice analysis technology, specifically focussing on social impact analysis using voice biomarkers.
biomarkers for oncology,Proteomics

Cancer: Breakthrough technologies allowing leveraging biomarkers for oncology

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, provides a cancer focus, in particular, she details breakthrough technologies that allow leveraging biomarkers for oncology.
biomakers

Biomarkers and patients’ access to personalised oncology drugs in Europe

Heinz Zwierzina M.D., CDDF Managing Director tells us all about biomarkers and patients’ access to personalised oncology drugs in Europe in this insightful article
didgital innovation

Digital innovation in diabetes: From health promotion to integrated care provision

Prof Dr Freimut Schliess, Director of Science & Innovation at the Profil Institut für Stoffwechselforschung GmbH shares his views on data-based solutions for diabetes.
Cancer therapy

The current and future challenges of personalised cancer therapy

Managing Director of The Cancer Drug Development Forum, Prof. H. Zwierzina reveals his opinions on the current and future challenges of personalised cancer therapy, including the need for biomarkers.

Follow Open Access Government